HK1112847A1 - Self-assembling peptides for promoting hemostasis - Google Patents

Self-assembling peptides for promoting hemostasis

Info

Publication number
HK1112847A1
HK1112847A1 HK08107928.4A HK08107928A HK1112847A1 HK 1112847 A1 HK1112847 A1 HK 1112847A1 HK 08107928 A HK08107928 A HK 08107928A HK 1112847 A1 HK1112847 A1 HK 1112847A1
Authority
HK
Hong Kong
Prior art keywords
self
assembling peptides
promoting hemostasis
hemostasis
promoting
Prior art date
Application number
HK08107928.4A
Other languages
English (en)
Inventor
Rutledge Ellis-Behnke
Shuguang Zhang
Gerald Schneider
Kwok-Fai So
David Tay
Yu-Xiang Liang
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36939225&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1112847(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Publication of HK1112847A1 publication Critical patent/HK1112847A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G23/00—Compounds of titanium
    • C01G23/04—Oxides; Hydroxides
    • C01G23/047—Titanium dioxide
    • C01G23/07—Producing by vapour phase processes, e.g. halide oxidation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J21/00—Catalysts comprising the elements, oxides, or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium, or hafnium
    • B01J21/06—Silicon, titanium, zirconium or hafnium; Oxides or hydroxides thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J37/00—Processes, in general, for preparing catalysts; Processes, in general, for activation of catalysts
    • B01J37/08—Heat treatment
    • B01J37/10—Heat treatment in the presence of water, e.g. steam
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B1/00—Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Environmental & Geological Engineering (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Geology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Thermal Sciences (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
HK08107928.4A 2005-04-25 2008-07-17 Self-assembling peptides for promoting hemostasis HK1112847A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67461205P 2005-04-25 2005-04-25
US75882706P 2006-01-13 2006-01-13
PCT/US2006/015850 WO2006116524A1 (en) 2005-04-25 2006-04-25 Compositions and methods for promoting hemostasis and other physiological activities

Publications (1)

Publication Number Publication Date
HK1112847A1 true HK1112847A1 (en) 2008-09-19

Family

ID=36939225

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08107928.4A HK1112847A1 (en) 2005-04-25 2008-07-17 Self-assembling peptides for promoting hemostasis

Country Status (12)

Country Link
US (3) US9327010B2 (xx)
EP (2) EP2283851B1 (xx)
JP (3) JP5204646B2 (xx)
KR (2) KR20100102750A (xx)
CN (1) CN101267831B (xx)
AU (1) AU2006241123B2 (xx)
CA (1) CA2609656C (xx)
DK (1) DK1879606T3 (xx)
ES (1) ES2427565T3 (xx)
HK (1) HK1112847A1 (xx)
IL (3) IL186779A (xx)
WO (1) WO2006116524A1 (xx)

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3031466B1 (en) 2004-07-06 2018-11-28 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
KR20100102750A (ko) 2005-04-25 2010-09-24 메사추세츠 인스티튜트 오브 테크놀로지 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및 방법
US9364412B2 (en) * 2005-11-14 2016-06-14 University Of Utah Research Foundation Electrostatically controlled hydrogels
ES2673947T3 (es) * 2006-04-25 2018-06-26 Massachusetts Institute Of Technology Composiciones y métodos para afectar al movimiento de contaminantes, líquidos corporales u otras entidades y/o afectar a otras condiciones fisiológicas
AU2014203694B2 (en) * 2006-04-25 2016-08-11 Massachusetts Institute Of Technology Compositions and methods for affecting movement of contaminants, bodily fluids or other entities and/or affecting other physiological conditions
ES2709125T3 (es) 2006-09-26 2019-04-15 Massachusetts Inst Technology Péptidos autoensamblantes modificados
US7696309B2 (en) * 2006-10-23 2010-04-13 The Brigham And Women's Hospital, Inc. Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
ES2400294T3 (es) * 2006-12-11 2013-04-08 3D Matrix, Inc. Composiciones y métodos para protección y regeneración del tejido cardiaco
EP2146733B1 (en) * 2007-03-14 2020-11-25 Arch Biosurgery, Inc. Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
US20110022149A1 (en) 2007-06-04 2011-01-27 Cox Brian J Methods and devices for treatment of vascular defects
US7906478B2 (en) * 2007-07-20 2011-03-15 The Procter & Gamble Company Personal-care articles having self-assembling peptides
MX2010005552A (es) 2007-11-21 2010-06-02 Smith & Nephew Aposito para heridas.
WO2009067711A2 (en) 2007-11-21 2009-05-28 T.J. Smith & Nephew, Limited Suction device and dressing
GB0722820D0 (en) 2007-11-21 2008-01-02 Smith & Nephew Vacuum assisted wound dressing
US20110002880A1 (en) * 2007-12-05 2011-01-06 3-D Matrix, Ltd. Material For Wound Healing and Skin Reconstruction
GB0723875D0 (en) 2007-12-06 2008-01-16 Smith & Nephew Wound management
US11253399B2 (en) 2007-12-06 2022-02-22 Smith & Nephew Plc Wound filling apparatuses and methods
US20090169521A1 (en) * 2007-12-31 2009-07-02 Technion Research & Development Foundation Ltd. Vascularized cardiac tissue and methods of producing and using same
GB0803564D0 (en) 2008-02-27 2008-04-02 Smith & Nephew Fluid collection
US8828358B2 (en) * 2008-03-11 2014-09-09 Materials Modifications, Inc. In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide
US8852558B2 (en) * 2008-03-11 2014-10-07 Materials Modification, Inc. In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide and platinum catalyst
AU2009232000B2 (en) * 2008-04-03 2014-12-11 Baxter International Inc. Hemostatic microspheres
BRPI0911923B8 (pt) 2008-05-02 2021-06-22 Sequent Medical Inc dispositivo para tratamento de um aneurisma cerebral
CN101302249B (zh) * 2008-06-24 2011-08-17 四川大学 一种自组装短肽及其在制备抗肿瘤药物中的应用
WO2010041636A1 (ja) * 2008-10-06 2010-04-15 株式会社スリー・ディー・マトリックス 組織閉塞剤
CN101514225B (zh) * 2008-10-13 2011-09-14 西安蓝晶生物科技有限公司 自聚体多肽及其制备方法和应用
KR101736169B1 (ko) * 2009-03-16 2017-05-16 닛산 가가쿠 고교 가부시키 가이샤 저분자 겔화제로 이루어진 스프레이용 기재
US20110054326A1 (en) * 2009-06-19 2011-03-03 Vanderbilt University Direct visualization catheter
US20110081398A1 (en) * 2009-10-01 2011-04-07 Tyco Healthcare Group Lp Multi-mechanism surgical compositions
CN102639181A (zh) 2009-11-05 2012-08-15 斯昆特医疗公司 多层长丝装置或血管缺损的治疗
WO2011072482A1 (en) * 2009-12-14 2011-06-23 The University Of Hong Kong Nano cancer barrier device(ncbd) to immobilize and inhibit the division of metastic cancer stem cells
WO2011084509A1 (en) * 2009-12-15 2011-07-14 Massachusetts Institute Of Technology Endothelial basement membrane targeting peptide ligands
WO2011106234A1 (en) 2010-02-25 2011-09-01 Provasculon, Inc. Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
US9687591B2 (en) 2010-03-31 2017-06-27 Agency For Science, Technology And Research Building stratified biomimetic tissues and organs using crosslinked ultrashort peptide hydrogel membranes
US8999916B2 (en) 2010-03-31 2015-04-07 Agency For Science, Technology And Research Crosslinked peptide hydrogels
WO2011123061A1 (en) 2010-03-31 2011-10-06 Agency For Science, Technology And Research Amphiphilic linear peptide/peptoid and hydrogel comprising the same
US9061095B2 (en) 2010-04-27 2015-06-23 Smith & Nephew Plc Wound dressing and method of use
GB201011173D0 (en) 2010-07-02 2010-08-18 Smith & Nephew Provision of wound filler
US8741833B2 (en) 2010-07-16 2014-06-03 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
WO2012069794A1 (en) 2010-11-25 2012-05-31 Smith & Nephew Plc Composition i-ii and products and uses thereof
GB201020005D0 (en) 2010-11-25 2011-01-12 Smith & Nephew Composition 1-1
US8546338B2 (en) 2010-12-08 2013-10-01 Johnson & Johnson Consumer Companies, Inc. Self-assembling hydrogels based on dicephalic peptide amphiphiles
JP6084352B2 (ja) * 2010-12-24 2017-02-22 国立大学法人 岡山大学 高強度ペプチドゲル
WO2012170495A1 (en) 2011-06-07 2012-12-13 Provasculon, Inc. Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1
AU2012295120A1 (en) 2011-08-14 2014-02-27 Materials Modification, Inc. Method and composition for in situ formation of an artificial blockage to control blood loss
EP2750687B1 (en) * 2011-09-02 2017-12-06 3-D Matrix, Ltd. Amphiphilic peptides for thoracic air leakage occlusion
US11260072B2 (en) 2011-09-07 2022-03-01 3-D Matrix, Ltd. MicroRNA-based methods and assays for osteocarcinoma
US10905708B2 (en) 2011-09-07 2021-02-02 3-D Matrix, Ltd. MicroRNA-based methods and assays for osteocarcinoma
GB2496654A (en) * 2011-11-18 2013-05-22 Reckitt & Colman Overseas Self-assembling peptides
US20150159066A1 (en) 2011-11-25 2015-06-11 Smith & Nephew Plc Composition, apparatus, kit and method and uses thereof
EP3466964A1 (en) * 2012-07-06 2019-04-10 3-D Matrix Ltd. Fill-finish process for peptide solutions
JP6183831B2 (ja) 2012-10-23 2017-08-23 義之 小山 ハイドロゲル形成材
US9241891B2 (en) 2012-10-30 2016-01-26 The Procter & Gamble Company Personal care compositions comprising self-assembling peptides
JP6376562B2 (ja) 2012-12-25 2018-08-22 扶桑薬品工業株式会社 止血剤アプリケータ
CN105102469A (zh) * 2013-01-28 2015-11-25 新加坡科技研究局 交联的肽水凝胶
KR101432276B1 (ko) * 2013-02-06 2014-08-21 주식회사 이노테라피 총경동맥 또는 상시상 정맥동에 출혈이 유발된 지혈제 성능평가 동물모델 및 그 용도
KR102045030B1 (ko) * 2013-02-08 2019-11-15 재단법인 아산사회복지재단 지혈요소가 구비된 의료기구
KR20150126394A (ko) * 2013-03-06 2015-11-11 가부시끼가이샤 쓰리디 매트릭스 정제된 양친매성 펩타이드 조성물을 이용하는 수술 방법
WO2014152751A1 (en) 2013-03-14 2014-09-25 Massachusetts Institute Of Technology Multi-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies
WO2014141160A1 (en) * 2013-03-14 2014-09-18 3-D Matrix, Ltd Treatment for bile leakage
JP6552115B2 (ja) * 2013-03-15 2019-07-31 クック・メディカル・テクノロジーズ・リミテッド・ライアビリティ・カンパニーＣｏｏｋ Ｍｅｄｉｃａｌ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｌｌｃ 消化管病変を治療するための接着性医療製品及び方法
US20160120706A1 (en) 2013-03-15 2016-05-05 Smith & Nephew Plc Wound dressing sealant and use thereof
US11931227B2 (en) * 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
JP6857857B2 (ja) * 2013-04-30 2021-04-14 国立大学法人九州工業大学 ペプチドおよびその自己集合方法、その集合体、これらを用いた細胞培養基材、並びに、細胞シートの製造方法
US10765774B2 (en) 2013-07-09 2020-09-08 Ethicon, Inc. Hemostatic pad assembly kit and method
US9955976B2 (en) 2013-08-16 2018-05-01 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9078658B2 (en) 2013-08-16 2015-07-14 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
JP6502352B2 (ja) * 2013-08-22 2019-04-17 アーチ・バイオサージェリー・インコーポレイテッド 流体の移動を制御するための移植可能なメッシュ
CN103656618B (zh) * 2013-10-25 2016-06-08 广东药学院 治疗皮肤创伤的多肽纳米纤维凝胶制剂、制备方法及应用
CN103665110B (zh) * 2013-12-06 2015-10-28 华南理工大学 半程电荷互补型手性自组装短肽纳米生物医药材料及应用
JP2015142720A (ja) * 2013-12-27 2015-08-06 株式会社メニコン 止血材
JP6490897B2 (ja) * 2013-12-27 2019-03-27 株式会社メニコンネクト 自己組織化ペプチドゲル
WO2015136370A2 (en) 2014-03-10 2015-09-17 3-D Matrix, Ltd. Sterilization and filtration of peptide compositions
WO2015138514A1 (en) 2014-03-10 2015-09-17 3-D Matrix, Ltd. Self-assembling peptide compositions
US10245299B2 (en) 2014-03-10 2019-04-02 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary bulla
JPWO2015145797A1 (ja) * 2014-03-28 2017-04-13 大塚化学株式会社 止血用医薬組成物
US9629635B2 (en) 2014-04-14 2017-04-25 Sequent Medical, Inc. Devices for therapeutic vascular procedures
WO2016006693A1 (ja) * 2014-07-11 2016-01-14 株式会社メニコン 視認性確保材および視認性確保材吐出装置
DE102015000363A1 (de) 2015-01-20 2016-07-21 Emc Microcollections Gmbh Neue modular funktionalisierbare Peptid-Hydrogele
JP6951252B2 (ja) * 2015-12-18 2021-10-20 株式会社スリー・ディー・マトリックス 止血用組成物、および、止血用組成物を用いた止血方法
US10814038B2 (en) 2016-01-06 2020-10-27 3-D Matrix, Ltd. Combination compositions
MX2018011201A (es) * 2016-03-18 2018-11-22 3 D Matrix Ltd Oclusion de fuga de liquido cefalorraquideo.
US20200078489A1 (en) * 2016-03-18 2020-03-12 3-D Matrix, Ltd. Pancreatic fistula occlusion
AU2017232540A1 (en) * 2016-03-18 2018-09-27 3-D Matrix, Ltd. Preventing biological tissue adhesion
EP3463496A1 (en) * 2016-06-01 2019-04-10 3-D Matrix Ltd. Hemostatic powders with self-assembling peptide hydrogels
EP3463495A1 (en) * 2016-06-01 2019-04-10 3-D Matrix Ltd. Hemostatic dressings with self-assembling peptide hydrogels
JP6912953B2 (ja) * 2016-06-27 2021-08-04 三洋化成工業株式会社 体液漏出防止剤
JP7012950B2 (ja) 2016-11-17 2022-01-31 地方独立行政法人東京都立産業技術研究センター 生体組織孔閉鎖用、潰瘍保護用及び血管塞栓療術用ゾル
US11174288B2 (en) * 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
CN106701724B (zh) * 2016-12-27 2019-10-08 江南大学 一种碱性果胶酶活性包涵体的制备及其应用
CN107529533B (zh) * 2017-09-07 2020-10-30 中国药科大学 一类可自组装成水凝胶的pH敏感多肽及其作为装载药物材料的应用
KR101989054B1 (ko) * 2017-11-28 2019-06-13 (주)다림티센 지혈용 조성물 및 이를 포함하는 용기
CN107802883B (zh) * 2017-12-09 2020-08-14 青岛市妇女儿童医院 一种伤口清洗液
US11324703B2 (en) 2017-12-15 2022-05-10 3-D Matrix, Ltd. Surfactant peptide nanostructures and uses thereof in drug delivery
WO2019182905A1 (en) 2018-03-23 2019-09-26 Arch Biosurgery, Inc. Sap and peptidomimetics for treatment of eye disease
CN112165952A (zh) 2018-03-23 2021-01-01 阿奇生物外科有限公司 用于减轻炎症症状的sap和拟肽组合物
CN108517006B (zh) * 2018-05-10 2021-05-28 暨南大学 一种常温常压条件下改善碳纳米管在水中分散性的多肽材料及其应用
JP7142286B2 (ja) * 2018-07-13 2022-09-27 慶應義塾 セレン含有アミノ酸を含む糖鎖－ポリペプチド複合体、および、その医薬用途
US20210220429A1 (en) * 2018-10-05 2021-07-22 Kurume University Pharmaceutical composition for treating or preventing ulcer or fistula in intestinal tract
CN109136165A (zh) * 2018-10-16 2019-01-04 罗忠礼 一种自组装短肽在皮肤组织创伤中快速修复的应用
CN109646711A (zh) * 2019-01-29 2019-04-19 青岛中腾生物技术有限公司 一种医用止血封闭防黏连材料
JP7469323B2 (ja) 2019-03-15 2024-04-16 マイクロベンション インコーポレイテッド 血管障害の治療のためのフィラメント状デバイス
WO2020190639A1 (en) 2019-03-15 2020-09-24 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US11291453B2 (en) 2019-03-15 2022-04-05 Sequent Medical, Inc. Filamentary devices having a flexible joint for treatment of vascular defects
CN110256572B (zh) * 2019-05-07 2022-11-01 西北大学 一种rhc-(rada)4融合蛋白
CN110396124B (zh) * 2019-08-21 2021-04-13 上海交通大学 自组装多肽及其作为止血剂的用途
EP4090350A1 (en) 2020-01-13 2022-11-23 Arch Biosurgery, Inc. Self-assembling peptide gel formulation and methods of use
CN112386737B (zh) * 2020-11-23 2022-07-26 上海交通大学 一种限制伤口部位的体液溢出的组合物
CN113046884B (zh) * 2021-03-25 2022-06-10 台州市中心医院（台州学院附属医院） 一种抗菌可降解医用缝合线
CN114230640A (zh) * 2021-12-21 2022-03-25 西安交通大学 一种具有自组装能力的氨基酸缩合物
US20240139380A1 (en) * 2022-05-04 2024-05-02 Massachusetts Institute Of Technology Formulations and medical devices for minimally-invasive deep tissue applications

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1006606A (en) 1961-05-12 1965-10-06 Fmc Corp Haemostatic wound dressing
US4098728A (en) 1976-01-02 1978-07-04 Solomon Rosenblatt Medical surgical sponge and method of making same
US4211227A (en) 1978-07-03 1980-07-08 The Kendall Company Surgical sponge material
US4272398A (en) 1978-08-17 1981-06-09 The United States Of America As Represented By The Secretary Of Agriculture Microencapsulation process
US4636208A (en) * 1984-10-05 1987-01-13 Ewald Rath Surgical sponge
US4829000A (en) 1985-08-30 1989-05-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Reconstituted basement membrane complex with biological activity
US4861627A (en) * 1987-05-01 1989-08-29 Massachusetts Institute Of Technology Preparation of multiwall polymeric microcapsules
US5019646A (en) 1987-08-25 1991-05-28 Regents Of The University Of Minnesota Polypeptides with fibronectin activity
US5843156A (en) 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
US5126141A (en) * 1988-11-16 1992-06-30 Mediventures Incorporated Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
CA2122041A1 (en) * 1989-12-04 1993-04-29 Kenneth Kensey Plug device for sealing openings and method of use
US5180375A (en) 1991-05-02 1993-01-19 Feibus Miriam H Woven surgical drain and woven surgical sponge
US5222974A (en) 1991-11-08 1993-06-29 Kensey Nash Corporation Hemostatic puncture closure system and method of use
JPH05204646A (ja) 1992-01-28 1993-08-13 Mitsubishi Electric Corp 知識処理システム
US5670483A (en) * 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5955343A (en) * 1992-12-28 1999-09-21 Massachusetts Institute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
FR2715309B1 (fr) 1994-01-24 1996-08-02 Imedex Composition adhésive, à usage chirurgical, à base de collagène modifié par coupure oxydative et non réticulé.
US6413539B1 (en) 1996-10-31 2002-07-02 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
WO1996040033A1 (en) 1995-06-07 1996-12-19 Clarion Pharmaceuticals Inc. Non-biological patch for hemostasis
US5645565A (en) 1995-06-13 1997-07-08 Ethicon Endo-Surgery, Inc. Surgical plug
CZ318998A3 (cs) 1996-04-04 1999-09-15 Baxter Aktiengesellschaft Hemostatická houba na bázi kolagenu, způsob její přípravy, kryt na ránu a kit k přípravě tohoto krytu
US6489446B1 (en) 1996-08-07 2002-12-03 Hsc Research And Development Limited Partnership Self-aligning peptides modeled on human elastin and other fibrous proteins
US6177609B1 (en) 1997-03-10 2001-01-23 Meadox Medicals, Inc. Self-aggregating protein compositions and use as sealants
US5906997A (en) 1997-06-17 1999-05-25 Fzio Med, Inc. Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
US6368877B1 (en) * 1997-06-25 2002-04-09 Massachusetts Institute Of Technology Self-assembling peptide surfaces for cell patterning and interactions
US6235340B1 (en) 1998-04-10 2001-05-22 Massachusetts Institute Of Technology Biopolymer-resistant coatings
JP4159682B2 (ja) 1998-12-22 2008-10-01 株式会社クラレ 止血材
WO2000041732A1 (en) * 1999-01-19 2000-07-20 The Children's Hospital Of Philadelphia Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof
WO2000063079A1 (en) * 1999-04-15 2000-10-26 Ultracell Medical Technologies Of Connecticut, Inc. Method for producing surgical sponge device and product thereof
JP4596341B2 (ja) 1999-11-11 2010-12-08 オリンパステルモバイオマテリアル株式会社 液体状創傷被覆材
US6844324B1 (en) * 1999-11-12 2005-01-18 Massachusetts Institute Of Technology Modular peptide mediated intracellular delivery system and uses therefore
CA2396810A1 (en) * 2000-01-24 2001-07-26 Phylos, Inc. Sensitive, multiplexed diagnostic assays for protein analysis
US20020010150A1 (en) 2000-04-28 2002-01-24 Cortese Stephanie M. Homostatic compositions of polyacids and polyalkylene oxides and methods for their use
US6953656B2 (en) * 2000-07-14 2005-10-11 Massachusetts Institute Of Technology Direct, externally imposed control of polypeptides
US6953659B2 (en) * 2000-07-14 2005-10-11 Massachusetts Institute Of Technology Direct, externally imposed control of nucleic acids
US6846319B2 (en) 2000-12-14 2005-01-25 Core Medical, Inc. Devices for sealing openings through tissue and apparatus and methods for delivering them
AR032800A1 (es) 2001-01-25 2003-11-26 Nycomed Pharma As Una suspension que comprende fibrinogeno, trombina y alcohol, un metodo para preparar dicha suspension, un metodo para recubrir un agente con dicha suspension, y un metodo para secar un recubrimiento de un agente, y una esponja de colageno recubierta
US7449180B2 (en) * 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
ATE419333T1 (de) 2001-02-06 2009-01-15 Massachusetts Inst Technology Peptidgerüstverkapselung von gewebszellen und verwendungen davon
JP3838882B2 (ja) 2001-02-28 2006-10-25 株式会社Ｐｈｇ 温度応答性材料およびそれを含む組成物
MXPA03010103A (es) 2001-05-04 2004-03-10 Scripps Research Inst Peptidos y composiciones anti-microbianos.
EP1408902A4 (en) 2001-06-22 2008-02-13 Millard Marsden Mershon COMPOSITIONS AND METHODS FOR REDUCING LIQUID AND BLOOD LOSS FROM OPEN WOUNDS
US7179784B2 (en) * 2001-07-10 2007-02-20 Massachusetts Institute Of Technology Surfactant peptide nanostructures, and uses thereof
WO2003052117A2 (en) * 2001-09-19 2003-06-26 Massachusetts Institute Of Technology Methods and products related to non-viral transfection
JP2003252936A (ja) 2002-02-28 2003-09-10 Sentomedo:Kk 温度応答性材料及びそれを含む組成物
AU2003222167A1 (en) 2002-04-02 2003-10-20 Northwestern University Peptide amphiphile solutions and self assembled peptide nanofiber networks
AU2003249606A1 (en) 2002-05-13 2003-12-02 Massachusetts Institute Of Technology Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
CA2387257C (en) * 2002-05-23 2009-07-28 Suncor Energy Inc. Static deaeration conditioner for processing of bitumen froth
GB0216286D0 (en) 2002-07-15 2002-08-21 Univ Leeds Network
EP1542709A2 (en) 2002-08-06 2005-06-22 EPIX Pharmaceuticals, Inc. Peptide aggregates
US7560276B2 (en) * 2003-06-27 2009-07-14 Ethicon, Incorporated Soft tissue repair and regeneration using postpartum-derived cells
WO2004110964A2 (en) 2003-06-16 2004-12-23 Nuevolution A/S Encoded molecules by translation (emt)
US7713923B2 (en) * 2003-06-25 2010-05-11 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
EP1636250B1 (en) * 2003-06-25 2016-01-06 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and uses thereof
JP2005074079A (ja) 2003-09-02 2005-03-24 Masao Tanihara 止血材
US7846891B2 (en) * 2003-10-17 2010-12-07 Massachusetts Institute Of Technology Self-assembling peptides for regeneration and repair of neural tissue
US20050266086A1 (en) * 2004-06-01 2005-12-01 Sawhney Amarpreet S Intrauterine applications of materials formed in situ
EP3031466B1 (en) * 2004-07-06 2018-11-28 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
US7884185B2 (en) 2004-07-28 2011-02-08 University Of Delaware Hydrogels and uses thereof
US8039258B2 (en) 2004-09-28 2011-10-18 Ethicon, Inc. Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
US7399831B2 (en) * 2004-10-25 2008-07-15 The Brigham And Women's Hospital, Inc. Targeted delivery of biological factors using self-assembling peptide nanofibers
CA2592292A1 (en) * 2005-01-04 2006-07-13 The Brigham And Women's Hospital, Inc. Sustained delivery of pdgf using self-assembling peptide nanofibers
KR20100102750A (ko) 2005-04-25 2010-09-24 메사추세츠 인스티튜트 오브 테크놀로지 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및 방법
US9162005B2 (en) 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
ES2673947T3 (es) 2006-04-25 2018-06-26 Massachusetts Institute Of Technology Composiciones y métodos para afectar al movimiento de contaminantes, líquidos corporales u otras entidades y/o afectar a otras condiciones fisiológicas
WO2007147002A2 (en) 2006-06-13 2007-12-21 Wisconsin Alumni Research Foundation Beta-peptide lyotropic liquid crystals and methods of manufacture and use thereof
ES2709125T3 (es) * 2006-09-26 2019-04-15 Massachusetts Inst Technology Péptidos autoensamblantes modificados
EP2146733B1 (en) 2007-03-14 2020-11-25 Arch Biosurgery, Inc. Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
US20120085262A1 (en) 2010-08-26 2012-04-12 Freudenberg Forschungsdienste Kg Production of Highly Concentrated Solutions of Self-Assembling Proteins
CN104244965A (zh) 2012-02-22 2014-12-24 西北大学 治疗癌症和其它病症的纳米结构

Also Published As

Publication number Publication date
US20090111734A1 (en) 2009-04-30
JP5629241B2 (ja) 2014-11-19
KR20080007380A (ko) 2008-01-18
CN101267831B (zh) 2013-04-24
AU2006241123A1 (en) 2006-11-02
KR20100102750A (ko) 2010-09-24
US11839694B2 (en) 2023-12-12
CA2609656A1 (en) 2006-11-02
EP2283851B1 (en) 2023-06-07
IL245530A (en) 2017-03-30
IL186779A0 (en) 2008-03-20
IL245530A0 (en) 2016-06-30
EP2283851A3 (en) 2011-06-08
EP2283851A2 (en) 2011-02-16
EP1879606B1 (en) 2013-06-12
JP2014221830A (ja) 2014-11-27
IL186779A (en) 2016-05-31
US20070203062A1 (en) 2007-08-30
JP5204646B2 (ja) 2013-06-05
JP2008539257A (ja) 2008-11-13
CN101267831A (zh) 2008-09-17
US20160296660A1 (en) 2016-10-13
AU2006241123B2 (en) 2013-10-03
US9364513B2 (en) 2016-06-14
WO2006116524A1 (en) 2006-11-02
CA2609656C (en) 2016-02-02
EP1879606A1 (en) 2008-01-23
IL250767B (en) 2019-02-28
IL250767A0 (en) 2017-04-30
JP2011168623A (ja) 2011-09-01
DK1879606T3 (da) 2013-09-23
US9327010B2 (en) 2016-05-03
ES2427565T3 (es) 2013-10-31

Similar Documents

Publication Publication Date Title
HK1112847A1 (en) Self-assembling peptides for promoting hemostasis
HK1221230A1 (zh) 新型肽化合物
HK1207009A1 (en) Absorbable hemostat
EP1957094A4 (en) CALCIUM-BINDING PEPTIDES
ZA200709239B (en) Compositions for administering RNAIII-inhibiting peptides
GB0508863D0 (en) Peptide
EP1912680A4 (en) PEPTIDES HER-2
EP1858914A4 (en) PEPTIDE NETWORKS
ZA200802571B (en) GDNF derived peptides
GB0514482D0 (en) Protein
GB0526120D0 (en) Therapeutic peptides
GB0526019D0 (en) Peptides
GB0516527D0 (en) Peptides
EP1939286A4 (en) NEW PEPTIDE
EP2097439A4 (en) NEW PEPTIDE
IL197675A0 (en) Peptides
GB0511861D0 (en) Proteins
GB0512969D0 (en) Peptides
GB0523953D0 (en) Peptides
GB0509835D0 (en) Peptide
GB0516303D0 (en) Peptide
GB0516302D0 (en) Protein
GB0504075D0 (en) Plac-1-like protein
GB0514789D0 (en) Protein
GB0508160D0 (en) Protein